Latest Insider Transactions at Ambrx Biopharma Inc. (AMAM)
This section provides a real-time view of insider transactions for Ambrx Biopharma Inc. (AMAM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Ambrx Biopharma Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Ambrx Biopharma Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 18
2023
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
751,233
+1.07%
|
$6,761,097
$9.24 P/Share
|
|
Sep 15
2023
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
1,401,505
+2.0%
|
$12,613,545
$9.05 P/Share
|
|
Sep 01
2023
|
Margaret Dalesandro |
BUY
Grant, award, or other acquisition
|
Direct |
195,833
+50.0%
|
-
|
|
Jun 07
2023
|
Steve C Glover Director |
BUY
Grant, award, or other acquisition
|
Direct |
85,000
+50.0%
|
-
|
|
Jun 07
2023
|
Kate Hermans Director |
BUY
Grant, award, or other acquisition
|
Direct |
85,000
+50.0%
|
-
|
|
Jun 07
2023
|
Paul V Maier Director |
BUY
Grant, award, or other acquisition
|
Direct |
85,000
+50.0%
|
-
|
|
Jun 07
2023
|
Janet Loesberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
85,000
+50.0%
|
-
|
|
Apr 26
2023
|
Daniel J. O'Connor President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
2,750,000
+50.0%
|
-
|
|
Apr 26
2023
|
Sonja Nelson Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,000,000
+50.0%
|
-
|
|
Apr 20
2023
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
886,634
+1.3%
|
$9,752,974
$11.6 P/Share
|
|
Apr 19
2023
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
951,909
+1.41%
|
$10,470,999
$11.15 P/Share
|
|
Apr 18
2023
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
3,376,646
+4.9%
|
$37,143,106
$11.27 P/Share
|
|
Apr 17
2023
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
562,121
+0.9%
|
$5,621,210
$10.67 P/Share
|
|
Apr 14
2023
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
841,967
+1.35%
|
$7,577,703
$9.96 P/Share
|
|
Apr 13
2023
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
1,193,808
+1.93%
|
$10,744,272
$9.16 P/Share
|
|
Mar 16
2023
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
500,000
+0.93%
|
$5,000,000
$10.15 P/Share
|
|
Mar 15
2023
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
250,000
+0.47%
|
$2,500,000
$10.6 P/Share
|
|
Mar 14
2023
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
250,000
+0.47%
|
$2,250,000
$9.95 P/Share
|